Jan 9, 20222 minPodcast: Minimizing Toxicity of Treatments for B Cell LymphomaMEI's drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells.
Oct 19, 20211 minPodcast: Developing Inhibitor Drugs for Use with Antibiotics to Combat Antimicrobial Drug ResistanceQpex is developing IV and oral drugs to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
Oct 10, 20211 minPocast: Focusing on Health Equity to Sustain a More Resilient Population: Sam Meraj of WalmartI think a lot is being done to address health equity, but yet we have an opportunity to do a lot more.